These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8992929)

  • 1. Cyclophosphamide-induced bladder cancer.
    Gossmann J
    Ann Intern Med; 1997 Jan; 126(1):86. PubMed ID: 8992929
    [No Abstract]   [Full Text] [Related]  

  • 2. Spindle cell cancer of bladder during cyclophosphamide therapy for Wegener's granulomatosis.
    Chasko SB; Keuhnelian JG; Gutowski WT; Gray GF
    Am J Surg Pathol; 1980 Apr; 4(2):191-6. PubMed ID: 7377464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous cell carcinoma of the bladder associated with cyclophosphamide therapy for Wegener's granulomatosis: a report of 2 cases.
    Stein JP; Skinner EC; Boyd SD; Skinner DG
    J Urol; 1993 Mar; 149(3):588-9. PubMed ID: 8437272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolving paradigm of cancer risk related to cyclophosphamide therapy in granulomatosis with polyangiitis.
    Calatroni M; Buzio C; Vaglio A
    Rheumatology (Oxford); 2015 Aug; 54(8):1339-41. PubMed ID: 26018438
    [No Abstract]   [Full Text] [Related]  

  • 5. What is proper treatment for Wegener granulomatosis?
    Inoue K; Yoshikawa T; Kawahito Y; Sano H
    Arch Intern Med; 2001 Jul; 161(14):1777-8. PubMed ID: 11485512
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis.
    Talar-Williams C; Hijazi YM; Walther MM; Linehan WM; Hallahan CW; Lubensky I; Kerr GS; Hoffman GS; Fauci AS; Sneller MC
    Ann Intern Med; 1996 Mar; 124(5):477-84. PubMed ID: 8602705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cyclophosphamide-induced bladder cancer in a patient with Wegener granuromatosis].
    Shimizu A; Ueda T; Furuya Y; Ichikawa T; Akakura K; Ito H; Matsuzaki O; Isaka S
    Nihon Hinyokika Gakkai Zasshi; 1999 Jan; 90(1):53-6. PubMed ID: 10067308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinosarcoma of the urinary bladder following cyclophosphamide therapy: evidence for monoclonal origin and chromosome 9p allelic loss.
    Mukhopadhyay S; Shrimpton AE; Jones LA; Nsouli IS; Abraham NZ
    Arch Pathol Lab Med; 2004 Jan; 128(1):e8-11. PubMed ID: 14692829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis.
    Faurschou M; Mellemkjaer L; Voss A; Keller KK; Hansen IT; Baslund B
    Rheumatology (Oxford); 2015 Aug; 54(8):1345-50. PubMed ID: 25234661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide-induced hepatitis in Wegener's granulomatosis.
    Du LT; Rigaud D; Papo T; Godeau P
    Mayo Clin Proc; 1994 Sep; 69(9):912-3. PubMed ID: 8065199
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide-induced hepatotoxicity in a patient with Wegener's granulomatosis.
    Snyder LS; Heigh RI; Anderson ML
    Mayo Clin Proc; 1993 Dec; 68(12):1203-4. PubMed ID: 8246624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does hepatocellular carcinoma develop after treatment of Wegener's granulomatosis with cyclophosphamide?
    Ueno T; Sata M
    Intern Med; 2003 May; 42(5):379-80. PubMed ID: 12793704
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
    Knight A; Askling J; Granath F; Sparen P; Ekbom A
    Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide-associated leukemia in Wegener's granulomatosis.
    Wheeler GE
    Ann Intern Med; 1981 Mar; 94(3):361-2. PubMed ID: 7224386
    [No Abstract]   [Full Text] [Related]  

  • 15. Bladder toxicity with chronic oral cyclophosphamide therapy in nonmalignant disease.
    Aptekar RG; Atkinson JP; Decker JL; Wolff SM; Chu EW
    Arthritis Rheum; 1973; 16(4):461-7. PubMed ID: 4722431
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytotoxic therapy for Wegener's granulomatosis.
    Morton CE; Easton DJ
    Lancet; 1984 Jun; 1(8391):1411. PubMed ID: 6145861
    [No Abstract]   [Full Text] [Related]  

  • 17. Stevens-Johnson syndrome induced by cyclophosphamide: report of two cases.
    Assier-Bonnet H; Aractingi S; Cadranel J; Wechsler J; Mayaud C; Saiag P
    Br J Dermatol; 1996 Nov; 135(5):864-6. PubMed ID: 8977704
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiomyopathy following intravenous cyclophosphamide therapy in a patient with Wegener's granulomatosis.
    Manthorpe R; Svensson O
    Clin Exp Rheumatol; 1996; 14(6):702-3. PubMed ID: 8978974
    [No Abstract]   [Full Text] [Related]  

  • 19. Paranasal sinus leiomyosarcoma after cyclophosphamide and irradiation.
    Lalwani AK; Kaplan MJ
    Otolaryngol Head Neck Surg; 1990 Dec; 103(6):1039-42. PubMed ID: 2126121
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary bladder cancer following cyclophosphamide therapy for Hodgkin's disease.
    Pathak AB; Advani SH; Gopal R; Nadkarni KS; Saikia TK
    Leuk Lymphoma; 1992 Dec; 8(6):503-4. PubMed ID: 1297484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.